Bristol-Myers Squibb Company provided earnings guidance for the year 2013. For the year, the company expects GAAP EPS guidance range from $1.54 to $1.64 and its non-GAAP EPS guidance range from $1.78 to $1.88. The company expects full-year gross margin as a percentage of sales between 72% and 73%.

The company effective tax rate of approximately 16%.